مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

286
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

84
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

ASSESSMENT OF THIOPURINE-BASED DRUGS ACCORDING TO THIOPURINE S-METHYLTRANSFERASE GENOTYPE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Pages

  32-38

Abstract

 For the past half century, thiopurines have earned themselves a reputation as effective anti-cancer and immunosuppressive drugs.Thiopurine S-methyltransferase (TPMT) is involved in the metabolism of all thiopurines and is one of the main enzymes that inactivates mercaptopurine. 6-MP is now used as a combination therapies for maintenance therapy of children with acute lymphocytic leukemia (ALL). In all patients receiving mercaptopurine, there is a risk of bone marrow suppression.TPMT activity is inherited as a monogenic, co-dominant trait. More than 25 variants are known. Genetic testing is available for several TPMT variant alleles. Most commonly TPMT*2, *3A, and *3C are tested for, which account for >90% of inactivating alleles. Differences in DNA that alter the expression or function of proteins that are targeted by drugs can contribute significantly to variation in the responses of individuals. Genotyping may become part of routine investigations to help clinicians tailor drug treatment effectively. This success is mainly due to the development of combination therapies and stratification of patients according to risk of treatment failure and relapse, rather than the discovery of new drugs. The aim of this study was to investigate the effect of genotype or methyltransferase enzyme activity before starting therapy in children with ALL. This can prevent the side effect of thiopurine drugs. In fact, the common POLYMORPHISM of this enzyme in population could be a prognostic factor in relation to drug use and treatment of patients with ALL.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    AZIMI, F., JAFARIAN, M., KHATAMI, S., MORTAZAVI, Y., & AZAD, M.. (2014). ASSESSMENT OF THIOPURINE-BASED DRUGS ACCORDING TO THIOPURINE S-METHYLTRANSFERASE GENOTYPE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 4(1), 32-38. SID. https://sid.ir/paper/320614/en

    Vancouver: Copy

    AZIMI F., JAFARIAN M., KHATAMI S., MORTAZAVI Y., AZAD M.. ASSESSMENT OF THIOPURINE-BASED DRUGS ACCORDING TO THIOPURINE S-METHYLTRANSFERASE GENOTYPE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY[Internet]. 2014;4(1):32-38. Available from: https://sid.ir/paper/320614/en

    IEEE: Copy

    F. AZIMI, M. JAFARIAN, S. KHATAMI, Y. MORTAZAVI, and M. AZAD, “ASSESSMENT OF THIOPURINE-BASED DRUGS ACCORDING TO THIOPURINE S-METHYLTRANSFERASE GENOTYPE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA,” IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, vol. 4, no. 1, pp. 32–38, 2014, [Online]. Available: https://sid.ir/paper/320614/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button